摘要
心力衰竭(HF)是各种心脏疾病的晚期阶段,死亡率和再住院率居高不下。伊伐布雷定可通过降低心率、改善心肌纤维化从而减少慢性HF患者的心血管死亡率、全因死亡率和再住院率,本文就伊伐布雷定的药学机制及其对各型慢性HF患者结局的影响作简要介绍。
Heart failure is the late stage of various heart diseases,and the mortality and readmission rate remain high.Irvabradine can reduce cardiovascular mortality,all-cause mortality and rehospitalization rate in patients with chronic heart failure by reducing heart rate and improving myocardial fibrosis.This paper briefly introduces the pharmaceutical mechanism of irvabradine and its effect on the outcome of patients with various types of chronic heart failure.
作者
丘美玲
蔡恒
李秋月
QIU Meiling;CAI Heng;LI Qiuyue(Shanxi Medical University,Taiyuan 030000,China;Department of Geriatric Cardiology,the Second Hospital of Shanxi Medical University,Tai yuan 030000,China)
出处
《中国全科医学》
北大核心
2023年第S01期113-117,共5页
Chinese General Practice
